Iantrek, Inc.
Clinical trials sponsored by Iantrek, Inc., explained in plain language.
-
New glaucoma surgery under the microscope: does it lower eye pressure Long-Term?
Disease control ENROLLING_BY_INVITATIONThis study follows 300 adults with open angle glaucoma who had surgery using the CycloPen system to lower eye pressure. Researchers will check if eye pressure drops by at least 20% and track any side effects for two years after surgery. The goal is to see how safe and effective t…
Sponsor: Iantrek, Inc. • Aim: Disease control
Last updated May 26, 2026 08:13 UTC
-
New eye surgery aims to lower glaucoma pressure without lifelong drops
Disease control ENROLLING_BY_INVITATIONThis study follows 300 people with open-angle glaucoma who have a special surgery called bio-reinforced canaloplasty. The surgery is designed to help fluid drain from the eye, lowering pressure inside the eye. Researchers will check how much the pressure drops and how long the ef…
Sponsor: Iantrek, Inc. • Aim: Disease control
Last updated May 26, 2026 08:09 UTC
-
Glaucoma surgery checked 5 years later: does it hold up?
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 250 people with open-angle glaucoma who had a special surgery to improve fluid drainage in the eye. Researchers will check eye pressure at 3, 4, and 5 years after surgery to see how well the results last. The goal is to understand the long-term benefits of this…
Sponsor: Iantrek, Inc. • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC